The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis
K Zarogoulidis, E Boutsikou… - … journal of cancer, 2009 - Wiley Online Library
Abstract Bone metastases occur in 20–40% of patients with lung cancer. Recent studies
demonstrate a direct antiproliferative effect of 3rd generation bisphosphonates (BPs) on lung …
demonstrate a direct antiproliferative effect of 3rd generation bisphosphonates (BPs) on lung …
[PDF][PDF] The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis
K Zarogoulidis, E Boutsikou, P Zarogoulidis… - Int. J …, 2009 - academia.edu
Bone metastases occur in 20–40% of patients with lung cancer. Recent studies demonstrate
a direct antiproliferative effect of 3rd generation bisphosphonates (BPs) on lung tumors …
a direct antiproliferative effect of 3rd generation bisphosphonates (BPs) on lung tumors …
[引用][C] The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis
K ZAROGOULIDIS, E BOUTSIKOU… - … journal of cancer …, 2009 - pascal-francis.inist.fr
The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …
[PDF][PDF] The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis
K Zarogoulidis, E Boutsikou, P Zarogoulidis… - researchgate.net
Bone metastases occur in 20–40% of patients with lung cancer. Recent studies demonstrate
a direct antiproliferative effect of 3rd generation bisphosphonates (BPs) on lung tumors …
a direct antiproliferative effect of 3rd generation bisphosphonates (BPs) on lung tumors …
The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis.
K Zarogoulidis, E Boutsikou, P Zarogoulidis… - … Journal of Cancer, 2009 - europepmc.org
Bone metastases occur in 20-40% of patients with lung cancer. Recent studies demonstrate
a direct antiproliferative effect of 3rd generation bisphosphonates (BPs) on lung tumors …
a direct antiproliferative effect of 3rd generation bisphosphonates (BPs) on lung tumors …
[引用][C] The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis
K ZAROGOULIDIS - Int J Cancer, 2009 - cir.nii.ac.jp
The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis
K Zarogoulidis, E Boutsikou… - … journal of cancer, 2009 - pubmed.ncbi.nlm.nih.gov
Bone metastases occur in 20-40% of patients with lung cancer. Recent studies demonstrate
a direct antiproliferative effect of 3rd generation bisphosphonates (BPs) on lung tumors …
a direct antiproliferative effect of 3rd generation bisphosphonates (BPs) on lung tumors …
The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis
K Zarogoulidis, H Lithoxopoulou, E Boutsikou… - 2009 - ikee.lib.auth.gr
Bone metastases occur in 20-40% of patients with lung cancer. Recent studies demonstrate
a direct antiproliferative effect of 3rd generation bisphosphonates (BPs) on lung tumors …
a direct antiproliferative effect of 3rd generation bisphosphonates (BPs) on lung tumors …
[引用][C] The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis
K Zarogoulidis, E Boutsikou, P Zarogoulidis… - International Journal of …, 2009 - cir.nii.ac.jp
The impact of zoledronic acid therapy in survival of lung cancer patients with bone
metastasis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
metastasis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
[PDF][PDF] The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis
E Eleftheriadou, GN Tzanakakis, I Kanakis… - academia.edu
Bone metastases occur in 20–40% of patients with lung cancer. Recent studies demonstrate
a direct antiproliferative effect of 3rd generation bisphosphonates (BPs) on lung tumors …
a direct antiproliferative effect of 3rd generation bisphosphonates (BPs) on lung tumors …